TY  - JOUR
T1  - An Overview on Irritable Bowel Syndrome Diagnosis and Management in Primary Health Care Centers
A1  - Aboud M. Alqhatani
A1  - Khalid A. Almutiri
A1  - Fatimah N. S Alfarj
A1  - Adeebah N R Nageeb
A1  - Marwan S J Alsulami
A1  - Mazin T Alshammari
A1  - Abdulrahman A. Al-Mutairi
A1  - Maha S. F Alanazi
A1  - Abdullah N. Attar
A1  - Asalah A. S. Alhazmi
JF  - Pharmacophore
JO  - Pharmacophore
SN  - 2229-5402
Y1  - 2020
VL  - 11
IS  - 5
SP  - 151
EP  - 155
N2  - Background: Irritable bowel syndrome is the most prevalent gastrointestinal disease characterized by recurrent abdominal pain or discomfort associated and relieved by defecation. Irritable Bowel Syndrome (IBS) is the most common functional gastrointestinal disorder where no obvious structural or biochemical etiology can be found. It is two times more prevalent in women than in men. Objective: In this study, we aim at giving an overview of IBS and the pathophysiology, predisposing factors, and management options. Methodology: We searched the PubMed database looking for relevant articles. Three mesh terms "Irritable Bowel Syndrome," "Pathophysiology", and "Management" were used. Conclusion: Irritable Bowel Syndrome (IBS) is a multifactorial disease in which one or multiple factors might be involved. It is classified according to the stool pattern to IBS with constipation, diarrhea, mixed, or unclassified. Management should involve and target various pathways, including the predominant symptoms and the believed predisposing factors, such as psychosocial factors, diet modifications, or enhance gut microbiota
UR  - https://pharmacophorejournal.com/article/an-overview-on-irritable-bowel-syndrome-diagnosis-and-management-in-primary-health-care-centers
ER  -